CME Group (CME)
(Delayed Data from NSDQ)
$224.43 USD
+0.16 (0.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $224.41 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$224.43 USD
+0.16 (0.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $224.41 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Zacks News
Top Research Reports for UPS, PetroChina & Honeywell
by Zacks Equity Research
Today's Research Daily features new research reports on 16 major stocks, including United Parcel Service (UPS), PetroChina Company (PTR) and Honeywell International (HON).
Cboe Global's (CBOE) August Volume Increases Year Over Year
by Zacks Equity Research
Cboe Global's (CBOE) Options, Futures and U.S. Equities volume reflect year-over-year increase in August. However, European Equities and global forex decline.
4 Stocks to Play After Trade Talks Are Set to Resume
by Christopher Vargas
The stock market picked up today after the US and China agreed to resume trade talks next month.
Probability 101: How Not to Be a Sucker
by Kevin Cook
We need science and math -- and STEM-savvy minds -- more than ever to help us inform decision making.
Nasdaq's (NDAQ) August Volume Increases Year Over Year
by Zacks Equity Research
Nasdaq's (NDAQ) August U.S. equity options and European options and futures volume reflect year-over-year increase.
CME Group (CME) Records Second-Highest Monthly ADV in August
by Zacks Equity Research
CME Group's (CME) August volumes of 24.3 million contracts reflect an increase of 53% year over year. Treasury futures and Metals marks record volumes.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Zacks Equity Research
Sector ETF report for IAI
MarketAxess Up More Than 100% in a Year: Is Upside Left?
by Zacks Equity Research
MarketAxess (MKTX) shares rally due to its favorable operating performance and strategic initiatives, which poise it for long-term growth.
Boeing 737 MAX and the FAA: A Clash of Culture and Convexity
by Kevin Cook
As we await results of NTSB and grand jury investigations, many questions linger about what went wrong.
How to Trade Unicorns Before They IPO
by Kevin Cook
A growing herd of unicorns and their founders and investors are finding liquidity without rushing to IPO
Top Research Reports: Bristol-Myers, CME Group, Chubb & More
by Kalyan Nandy
Today's Research Daily features updated research reports on 16 major stocks, including Bristol-Myers (BMY), CME Group (CME) and Chubb (CB).
Cboe Global's (CBOE) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Cboe Global's (CBOE) second-quarter earnings gain from solid contributions by its Options segment.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
Intercontinental Exchange (ICE) Q2 Earnings & Revenues Top
by Zacks Equity Research
Intercontinental Exchange (ICE) Q2 reflects strength in global energy business and compounding growth in subscription-based Data & Listings business.
CME Group (CME) Q2 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
CME Group (CME) Q2 reflects better revenues and second-highest quarterly average daily volume.
CME Group (CME) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 0.57% and -0.63%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for CME Group (CME) This Earnings Season?
by Zacks Equity Research
CME Group's (CME) second-quarter results are likely to be driven by its strong market position and varied derivative product lines.
MarketAxess (MKTX) Q2 Earnings Miss Estimates But Rise Y/Y
by Zacks Equity Research
MarketAxess' (MKTX) second-quarter earnings miss estimates as rise in expenses outweigh revenue growth.
CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Northrop Grumman, Thermo Fisher Scientific, Newmont Goldcorp, Starbucks and CME
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Northrop Grumman, Thermo Fisher Scientific, Newmont Goldcorp, Starbucks and CME
Nasdaq (NDAQ) Reports Mixed Q2 Volumes, June Volume Down
by Zacks Equity Research
Nasdaq's (NDAQ) Q2 volumes reflect higher volumes of U.S. equity and European options but lower cash European and U.S. fixed income equity volume.
Can Fed Put Counter Potential Negative Q2 Earnings? 5 Picks
by Nalak Das
Fed's rate cut will not only make cheaper funds available to businesses and stock market investors, but also U.S. dollar less expensive in the international market.
Should You Invest in the iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI)?
by Sweta Killa
Sector ETF report for IAI
Intercontinental Exchange (ICE) Reports Lower June Volumes
by Tanuka De
Intercontinental Exchange's (ICE) June volumes reflect lower Financial average daily volumes partially offset by higher Commodities volumes.
Here's Why Investing in MarketAxess (MKTX) Makes Sense Now
by Zacks Equity Research
Riding high on the growing revenue base, solid international business and strategic initiatives, MarketAxess (MKTX) holds potential to reap benefits for investors.